Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;71(1):116-32.
doi: 10.1016/j.jaad.2014.03.023. Epub 2014 May 9.

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies

Lawrence F Eichenfield  1 , Wynnis L Tom  1 , Timothy G Berger  2 , Alfons Krol  3 , Amy S Paller  4 , Kathryn Schwarzenberger  5 , James N Bergman  6 , Sarah L Chamlin  7 , David E Cohen  8 , Kevin D Cooper  9 , Kelly M Cordoro  2 , Dawn M Davis  10 , Steven R Feldman  11 , Jon M Hanifin  3 , David J Margolis  12 , Robert A Silverman  13 , Eric L Simpson  3 , Hywel C Williams  14 , Craig A Elmets  15 , Julie Block  16 , Christopher G Harrod  17 , Wendy Smith Begolka  18 , Robert Sidbury  19
Affiliations

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies

Lawrence F Eichenfield et al. J Am Acad Dermatol. 2014 Jul.

Abstract

Atopic dermatitis is a common and chronic, pruritic inflammatory skin condition that can affect all age groups. This evidence-based guideline addresses important clinical questions that arise in its management. In this second of 4 sections, treatment of atopic dermatitis with nonpharmacologic interventions and pharmacologic topical therapies are reviewed. Where possible, suggestions on dosing and monitoring are given based on available evidence.

Keywords: antihistamines; antimicrobials; atopic dermatitis; bathing; calcineurin inhibitors; corticosteroids; emollients; topicals; wet wraps.

PubMed Disclaimer

Comment in

  • Management of Atopic Dermatitis.
    Stein SL, Cifu AS. Stein SL, et al. JAMA. 2016 Apr 12;315(14):1510-1. doi: 10.1001/jama.2016.1459. JAMA. 2016. PMID: 27115267 No abstract available.

References

    1. Nankervis H, Maplethorpe A, Williams HC. Mapping randomized controlled trials of treatments for eczema--the GREAT database (the Global Resource of EczemA Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010) BMC dermatology. 2011;11:10. - PMC - PubMed
    1. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". Journal of the American Academy of Dermatology. 2004;50:391–404. - PubMed
    1. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. Journal of the European Academy of Dermatology and Venereology : JEADV. 2012;26:1176–1193. - PubMed
    1. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. Journal of the European Academy of Dermatology and Venereology : JEADV. 2012;26:1045–1060. - PubMed
    1. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al. Atopic dermatitis: a practice parameter update 2012. The Journal of allergy and clinical immunology. 2013;131:295–299. e1–e27. - PubMed

Publication types

MeSH terms